Tower Research Capital (TRC)’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Tower Research Capital (TRC)’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,161	Closed	-$14K	–	6760
2022 Q4	$14K	Buy	3,161 +3,065	+3,193%	+$21.3K	﹤0.01%	3562
2022 Q3	$1K	Hold	96	–	–	﹤0.01%	5958
2022 Q2	$1K	Sell	96 -1	-1%	-$10	﹤0.01%	5973
2022 Q1	$1K	Hold	97	–	–	﹤0.01%	5978
2021 Q4	$1K	Hold	97	–	–	﹤0.01%	6004
2021 Q3	$1K	Hold	97	–	–	﹤0.01%	5627
2021 Q2	$1K	Buy	+97	New	+$945	﹤0.01%	5332

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Tower Research Capital (TRC)'s PKBO Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Peak Bio, Inc. Common Stock (PKBO) in Q1 2023, closing a stake of 3,161 shares — an estimated $14K sold.

Tower Research Capital (TRC) first reported a position in PKBO in Q2 2021 and held it in 7 quarters. The position peaked at $14K in Q4 2022. 1 fund tracked by Wall St. Rank holds PKBO as of Q1 2023.

Tower Research Capital (TRC) reported no remaining Peak Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 3,161 Peak Bio, Inc. Common Stock shares in Q1 2023, an estimated $14K.
Tower Research Capital (TRC) first reported a position in Peak Bio, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Tower Research Capital (TRC)'s Peak Bio, Inc. Common Stock position peaked at $14K in Q4 2022.
1 fund tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.